ArticleCurrent drug discovery technologies2026
Antibacterial Investigation of Saharan Propolis Coating on Conventional Surgical Threads.
Article in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionConventional surgical threads (CST) are often colonized with drug-resistant polymicrobial biofilms. However, such bioactive agent-incorporated CST are needed to solve this problem. The aim of this study was to develop a coating for CST consisting of the antibacterial Ethanolic Extract of Sahara Propolis (EESP) as a release topical delivery system for treating wounds, characterize the EESP and study the release profiles and antibacterial activity of EESP-CST against RESULTS AND DISCUSSION: According to the FTIR, 1H and 13C NMR analysis, the EESP through its various peaks and the various functional groups were detected. Besides, the propolis powder showed a very low degree of crystalline material (amorphous structure) as observed by X-ray powder diffraction. Exposure to EESP-CST short-term resulted in a significant reduction in absorbance at 90 min of exposure for S. aureus in MHB. In addition, the EESP-CST has not shown any significant reduction in absorbance after on for
Indexed as
Identifiers
40739690What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.